Guest Columns
-
Can Our Current Operational Processes Survive In 2025 And Beyond?
12/19/2024
As long as operating procedure improvements are confined to a single function or sub-area, the benefits will be limited to that context. What can we do for true process improvement across our organization?
-
AP Biosciences' Approach To Complex Antibody Manufacturing
12/19/2024
The bispecific developer's vice president of antibody discovery, Jhong-Jhe You, digs into the company's approach to purification and analytics.
-
Survey Findings: How Are IDMP Readiness Efforts Progressing?
12/13/2024
ISO Identification of Medicinal Products (IDMP) standards were designed to harmonize the way the life sciences industry records and manages data about its products. Companies’ state of readiness to implement and harness IDMP still varies.
-
Cell Culture Trends To Watch In 2025
12/12/2024
Three upstream processing experts weigh in on advancements from the past year and what they're looking forward to in the year ahead.
-
Why Aren't QC Labs Automated? Blame Sample Container Variability
12/11/2024
Members of the Laboratory Automation Plug and Play group speak up about the factors they see holding back quality control labs from achieving more robust automation.
-
Stage 3a: A Key Indicator For Process Validation Maturity
12/9/2024
Process validation's stage 3a serves to reconfirm the assumptions made during design space development and is particularly pronounced for new modalities and emerging processes.
-
5 Characteristics Of Forward-Thinking Microbiology Labs In 2025
12/6/2024
Improving microbiology laboratory efficiency is a continuum. Here are five tech-forward trends that will impact cost and efficiency in 2025.
-
The Building Blocks For Successful CDMO–Pharma Relationships For Packaging Operations
12/4/2024
The building blocks of such successful packaging relationships include a thoughtful approach to quality service agreements, a culture of transparency, and more.
-
2024 Survey Findings: How Is The "Lab Of The Future" Becoming Reality?
12/3/2024
The Pistoia Alliance conducted a survey as a pulse check on which technologies the pharma/biotech industry is investing in and companies' progress integrating new tech into the lab.
-
USP Chapter Covers Residual DNA Testing Practices For CHO And E. coli
12/3/2024
Industry widely uses qPCR to measure residual DNA; however, the technique lacked a standard. USP's General Chapter <509> aims to remedy that.